Home MagAssist Showcases Innovations in Mechanical Circulatory Support at ESAO 2025 and Files IPO Prospectus

MagAssist Showcases Innovations in Mechanical Circulatory Support at ESAO 2025 and Files IPO Prospectus

Aug 04, 2025 19:42 CST Updated 19:42
magAssist

Developer of Extracorporeal Artificial Heart Devices

Image


June 25-28, 2025magAssist (Suzhou) Co., Ltd. (hereinafter referred to as "magAssist")Wonderful Debut at Enschede, Netherlands51st European Society for Artificial Organs (ESAO)The Conference. As the annual academic conference in the field of artificial organs, this year's ESAO Conference brings together top experts from around the world in biomedical engineering, cardiology, and translational science to discuss the cutting-edge advancements and future trends in artificial organ technology.


Image


Concentrated Display of Innovative Achievements


At magAssist's booth, several groundbreaking technological achievements in the mechanical circulatory support (MCS) field attracted widespread attention. The company showcased the latest advancements in extracorporeal ventricular assist devices (extracorporeal VAD), percutaneous ventricular assist devices (pVAD), and extracorporeal membrane oxygenation (ECMO) systems, with core highlights including:


  • Design of Pump Drive System for Next-Generation Percutaneous Ventricular Assist Devices, Using Innovative Engineering Structures to Enhance Equipment Performance

  • A modular platform supporting multi-indication therapy, enabling flexible configuration of personalized treatment plans

  • The Hemodynamic Support Technology of Foldable Pumps in High-Risk Percutaneous Coronary Intervention (PCI) Provides Assurance for Complex Surgeries

  • Flow Field Optimization in Oxygenator Design Significantly Enhances Gas Exchange Efficiency

  • An Integrated Modeling Framework for Precision Treatment and Real-Time Optimization to Drive Data-Driven Clinical Decision-Making


Image


Academic Achievements Reach the International Stage


magAssist's team presented a series of high-level academic reports at the conference, comprehensively showcasing the company's cutting-edge research and innovative achievements in the field of mechanical circulatory support.


magAssist Vice President Mr. Yifan Yan Delivered Two Important Keynote Speeches:


  • An Integrated Modeling Framework for Mechanical Circulatory Support: Enabling Real-Time Hemodynamic Insights and Optimization

  • Modular Integration of Mechanical Circulatory Support: A Unified Platform for Multi-Indication Therapy


Image


Dr. Jia-Hao Xu, Senior Director of Science and Innovation at magAssist, shared technical insights from an engineering perspective:


  • "Design of the Drive System for Advanced Percutaneous Ventricular Assist Devices: An Engineering Perspective"

  • 《NyokAssist®️Performance of Percutaneous Transvalvular Ventricular Assist Device in High-Risk Percutaneous Coronary Intervention


Image


magAssist Scientist Ms. Wu Tingting Presents Three Technical Research Reports:


  • "A Novel Optimized Method for Reducing the Dual-Low Region in Oxygenators"

  • Mechanical Circulatory Support for Ventricular Septal Defect: A Simulation Study Based on Lumped Parameter Models

  • "Expandable Percutaneous Micro-Axial Flow Blood Pump: Precision Hydraulic Performance Measurement Technology"


Image


These academic reports fully demonstrate magAssist's firm determination and outstanding strength in promoting the translational research of mechanical circulatory support and facilitating data-driven treatment optimization.


Deepen International Cooperation and Industry Exchange


In addition to the rich academic agenda, the magAssist team engaged in in-depth exchanges with clinical experts, research scholars, and industry partners from Aachen and the global mechanical circulatory support field. At magAssist's on-site booth, the team established extensive connections with experts from the international academic and clinical practice communities, conducted in-depth discussions on clinical needs, and jointly envisioned the future development direction of artificial organ technology.


Image


About ESAO Organization


The European Society for Artificial Organs (ESAO) was founded in Geneva in 1974 and is an authoritative international organization promoting the science of artificial organs and regenerative medicine globally. ESAO has long focused on key areas such as cardiac assist devices, biomaterials, computational modeling, and tissue engineering, playing a crucial role in leading the development direction of life support technologies.


magAssist's impressive appearance at the ESAO conference not only showcased the innovative strength of China's medical technology enterprises but also contributed Chinese wisdom and solutions to the advancement of global mechanical circulatory support technologies.


Further Reading

Swipe up to view

Nanjing First Hospital Successfully Completes PCI Treatment in a Complex High-Risk Coronary Heart Disease (CHIP) Patient Under Extracorporeal Ventricular Assist Device Support

magAssist NyokAssist® 9Fr Artificial Heart Presents Interim Clinical Results at ISHLT 2025 Conference

Extracorporeal Left Heart Assist Replaces ECMO+IABP Combination: Zhujiang Hospital's Cardiothoracic Surgery Department Pioneers New Approaches in Heart Failure Treatment
The First Case in Guangdong Province After Marketing! Professor Xie Shaobo's Team from the First Affiliated Hospital of Guangzhou Medical University Assists Acute Heart Failure Patients to Stably Transition to Heart Transplantation with a Maglev Artificial Heart Produced in China
Huai'an No.1 Hospital Successfully Performs the First High-Risk Surgery with Extracorporeal Ventricular Assist in Jiangsu Prefecture-Level Public Hospital
A Turning Point Creates New Opportunities: Xinjiang Autonomous Region People's Hospital Uses magAssist's Minimally Invasive Extracorporeal Ventricular Assist Device MoyoAssist® to Successfully Bridge to Long-term Left Ventricular Assist
Kunhua Hospital Applies magAssist® China-Produced Magnetic Levitation Extra VAD® to Assist High-Risk PCI Patients in Revascularization Surgery
Xi'an No.1 Hospital Completes Minimally Invasive Extra VAD®-Assisted One-Stop TAVR-PCI for Elderly Complex Patients

Asian Heart Valve Forum China: Focus on "Safe and Effective" and "Cost-Effective" Extracorporeal Ventricular Assist

ISMCS 2024 | magAssist Showcases World's Smallest pVAD Clinical Progress and Other Latest Technological Achievements, Competing Alongside International Giants!
Heavyweight: Suzhou Successfully Bids for the International Society of Mechanical Circulatory Support Annual Meeting (ISMCS 2026)
TCT 2024 | Professor Ge Junbo's team from Zhongshan Hospital, Shanghai, shares the latest progress of the domestically developed world's smallest interventional ventricular assist system
The First Extra-VAD Standardized Training Course Successfully Held! Continuously Promoting the Standardized Training and System Construction of Extracorporeal Ventricular Assist Technology in China
magAssist MoyoAssist® Grand Launch! Successful Hosting of the Medium- and Short-Term Mechanical Circulatory Support Forum and Extra-VAD Clinical Technology Transformation Achievements Release

Recognized by Both China and the U.S., Transforming the Innovation Trend of Such Devices | magAssist's Minimally Invasive Interventional Artificial Heart Approved as an Innovative Medical Device!


#magAssist  #NyokAssist® #Ventricular Assist Device #IABP  #High-risk PCI


· END ·


Image

Copyright and Disclaimer:Yanda Medical Network aims to build a platform for academic dissemination and media communication. The copyright of the information in the article belongs to the holder, and we only provide the service of transmitting information. If there is any infringement, please contact us to delete it.

For more information, click"Read the original text"Download"Yanda Medical Voice APP"